1 de 10 sur environ 39 communiqués.
Worksport Ltd
TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Worksport Ltd (OTC: WKSP) (or the “Company”) is announcing that - due to overwhelming demand - its Regulation-A public offering has officially been...
First Choice Bancorp
CERRITOS, CALIFORNIA, Dec. 07, 2020 (GLOBE NEWSWIRE) -- (Nasdaq Capital Markets: FCBP) - First Choice Bancorp, the holding company for First Choice Bank (the “Bank” or “First Choice”), today...
Standard Uranium Corp.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard...
Standard Uranium Corp.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 10, 2020 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard...
Standard Uranium Corp.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, British Columbia, June 08, 2020 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard...
Standard Uranium Corp.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard...
Vislink Technologies, Inc.
NEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”)(Nasdaq: VISL), today announced the pricing of an underwritten public offering with expected total...
Praxsyn Corporation
WEST PALM BEACH, Florida, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Praxsyn (OTC:PXYN, the “Company”) is pleased to announce that it is currently processing portfolios for funding with its funding partner...
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
1 de 10 sur environ 39 communiqués.
